Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $377.5600 (0.75%) ($373.6325 - $380.5900) on Thu. Mar. 10, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.65% (three month average) | | RSI | 44 | | Latest Price | $377.5600(0.75%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN declines -1.2% a day on average for past five trading days. | | Weekly Trend | REGN declines -0.3% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(64%) XLV(51%) XBI(48%) QQQ(41%) IVW(40%) | | Factors Impacting REGN price | REGN will decline at least -1.325% in a week (0% probabilities).
VIXM(-12%) UUP(-8%) TLT(-8%) SHY(-4%) IPO(-4%) | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.325% (StdDev 2.65%) | | Hourly BBV | 0 () | | Intraday Trend | 0.2% | | | | | |
|
| Resistance Level | $392.46 | | 5 Day Moving Average | $391.84(-3.64%) | | 10 Day Moving Average | $395.43(-4.52%) | | 20 Day Moving Average | $392.46(-3.8%) | | To recent high | -32.5% | | To recent low | 3.2% | | Market Cap | $40.032b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |